In an effort to control healthcare costs, provide healthcare to the uninsured and underinsured, and improve health outcomes, there has been growing interest among politicians and the public
The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing
pharmaphorum caught up with Erik Nordkamp, outgoing president of the Association of the British Pharmaceutical Industry (ABPI), who has also changed role at Pfizer to become the organisatio
